NEW YORK (GenomeWeb News) – The National Institutes of Health has appointed Alan Guttmacher to serve as director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Guttmacher started working with NIH as a special assistant to the director of the National Human Genome Research Institute, then Francis Collins, and he became NHGRI's deputy director in 2002 and acting director in 2008. While at the NHGRI, Dr. Guttmacher also oversaw the NIH's involvement in the Surgeon General's Family History Initiative, an effort to encourage Americans to learn about and use their families' health histories to promote personal health and prevent disease.
"As a pediatrician, geneticist, and highly regarded leader at NIH over the last decade, Alan has the experience and the vision to lead the NICHD during what promises to be the most exciting time for science as well as for women's and children's health," Collins said in a statement.
Didier Hirsch has been named CFO and senior VP at Agilent Technologies. Hirsch has been acting CFO and VP of corporate controllership and tax at the company since April. Before joining Agilent, he was director of finance and administration for Hewlett-Packard Europe, Middle East, and Africa, and before that he held a similar post in HP's Asia Pacific business.
Pressure Biosciences has elected Alan Goldberg to serve on its board of directors. Goldberg has worked in commodities and finance. In 2009, he bought around $110,000 of convertible preferred stock and warrants in Pressure Bio in a private securities placement.
Jacques Simard has become the chair of Genome Canada's science and industry advisory committee, which provides strategic advice on approaches and directions to the organization's board of directors. He is a professor in the department of molecular medicine at Laval University and director of the endocrinology and genomics axis at the Centre Hospitalier Universitaire de Québec Research Centre.
PharmaNet Development Group announced this week that Riaz Bandali has joined the company as president of early-stage development. He will be based at the company's Montreal facility. Previously, Bandali was senior vice-president of strategy and business development at AB Sciex and Molecular Devices.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.